85% of trials do not meet study endpoints, often due to outcomes based on outdated literature that impacts the power and sample size of studies. As oncology clinical trials are restarted and redesigned, the need for accurate insights into outcomes and patient availability has become all the more critical.
This mini-webinar will explore how innovative and advanced data and AI technologies can inform patient cohort sizes and statistical power considerations. This webinar will feature our recently launched Digital Trial Optimization SaaS solution, which uses powerful oncology real-world data combined with AI-enabled technologies. This is part of our series of short webinar practicums that illustrate how real-world data and technology solutions in oncology can support novel study designs.